Digital Patient Monitoring Devices Market Size, Share & Trends Analysis Report By Type (Wireless Sensor Technology, mHealth, Telehealth, Wearable Devices, Remote Patient Monitoring), By Product, By Region, And Segment Forecasts, 2021 - 2028

Report Overview

The global digital patient monitoring devices market size was estimated at USD 62.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 23.5% from 2021 to 2028. Rising demand for continuous monitoring devices and increasing prevalence of chronic diseases such as diabetes, hypertension, cardiovascular diseases, and others are factors propelling the growth of the market.

In recent years, the adoption of sensor-based wearable devices such as continuous glucose monitors, ECG, and others is increasing among patients as well as healthcare providers. These devices can track the patient’s vital signs on a real-time basis which can then be transmitted to their doctors electronically and can also be integrated with the EHR. This allows the providers to continuously monitor the patient eliminating the need for frequent hospital visits. The rising demand for wearable devices has encouraged key players to carry intensive research and launch innovative products in the market for digital patient monitoring devices. For example, in March 2020, Somatix, Inc. announced the launch of an AI-powered continuous remote patient monitoring system. The introduction of similar innovative products is anticipated to augment the digital patient monitoring device market growth.

Incorporating digital patient monitoring systems can help in significant cost savings, thereby reducing the overall healthcare cost. Many countries across the globe are dealing with the economic burden of chronic diseases. According to the Centers for Disease Control and Prevention, heart disease and stroke costs around USD 214 billion to the U.S. healthcare system every year. With the use of digital patient monitoring systems, people at risk can be monitored remotely, thus preventing hospitalization and reducing healthcare costs. This is likely to favor the growth of the market for digital patient monitoring devices in the coming years.

COVID19 digital patient monitoring devices market impact: 32% growth from 2019 to 2020

The COVID-19 pandemic brought a digital revolution in the healthcare industry by increasing the demand for wearable devices, mHealth apps, and telehealth by multiple folds. To control the spread of infection and patient volumes, hospitals were forced to shut down their OPDs and shift to digital health. According to a survey conducted by VivaLNK, a connected healthcare solution provider, 55% of the respondents were using or planning to use Remote Patient Monitoring (RPM) for COVID-19 patients.

The government of many countries has started embracing digital health tools after realizing their potential. For instance, in April 2020, the Federal Communications Commission started a COVID-19 relief program which provided USD 200 million to equip hospitals with telehealth technology. This has opened new opportunities for the market players and start-up companies to develop innovative solutions. For example, in May 2020, VitalConnect, Inc. received Emergency Use Authorization from the USFDA for its cardiac monitoring device VitalPatch for use in COVID-19 patients. 

Type Insights

The wearable devices segment dominated the market for digital patient monitoring devices and accounted for the largest revenue share of 30.4% in 2020. Increasing adoption of connected devices and rising end-user preference for sophisticated gadgets are factors attributable to the prominent share of the segment. The mHealth segment is projected to witness substantial growth during the forecast period. Rising internet penetration and the growing number of smartphone users are expected to drive the growth of the segment. Furthermore, the increasing number of startups entering the market for digital patient monitoring devices is fueling segment growth. For instance, in August 2020, Undermyfork, an app for tracking diabetes received funding of USD 0.4 million. The app is about to be launched in the U.S.

Product Insights

Based on product, the diagnostic monitoring devices segment dominated the market for digital patient monitoring devices and accounted for the largest revenue share of 62.5% in 2020. The increasing prevalence of diseases such as diabetes, obesity, cancer, and others and the rising geriatric population are propelling the growth of the segment. According to the International Diabetes Federation, around 463 million people are living with diabetes in 2019 and the number is projected to reach 700 million by 2045. This is likely to favor the growth of the segment.

Apart from this, increasing demand for respiratory monitors such as pulse oximeters especially among COVID-19 patients is poised to surge the therapeutic monitoring devices segment growth. Furthermore, a growing number of strategic partnerships among key manufacturers are expected to positively impact the segment. For instance, in June 2020, Abbott partnered with Tandem Diabetes Care. Under this partnership, Abbott combined its Continuous Glucose Monitoring (CGM) technology with Tandem Diabetes Care’s insulin delivery systems.

Regional Insights

North America dominated the market for digital patient monitoring devices and accounted for the largest revenue share of 41.3% in 2020. Strong government support to reduce the healthcare cost burden, technological advancements, and the launch of new products are responsible for the dominant share of the region. In July 2020, Medtronic announced 510(k) clearance from U.S. FDA approval for LINQ II insertable cardiac monitor. This coupled with rising cases of heart diseases is expected to drive the market for digital patient monitoring devices in North America.

In Europe, the market for digital patient monitoring devices is likely to propel owing to the favoring government policies for mHealth and telehealth. In January 2019, NHS announced its long-term plan to make telehealth and mHealth a standard of care by 2022-23. This is expected to favor market adoption in Europe. Asia Pacific is anticipated to witness remarkable growth owing to the highest number of smartphone users in China and India and deeper internet penetration. According to India Cellular and Electronics Association, smartphone users in India are projected to increase from 500 million in 2019 to 820 million by 2022. This is likely to favor the market for digital patient monitoring devices in Asia Pacific.

Key Companies & Market Share Insights

Abbott emerged as one of the market leaders due to its strong product portfolio, update of current products as per patient needs, and wide geographical foothold. Apart from this, Koninklijke Philips N.V. held a prominent position in the market owing to the company’s strong focus on R&D. In June 2020, Koninklijke Philips N.V. launched Avalon CL Fetal and Maternal Patch and Pod, an obstetrics monitoring solution, in the U.S. Some of the prominent players in the digital patient monitoring devices market include:

• GE Healthcare

• AT&T

• ATHENAHEALTH, INC.

• Abbott

• Koninklijke Philips N.V. AB

• Hill-Rom Services Inc.

• Medtronic

• Omron Healthcare, Inc.

• FitBit, Inc.

• Garmin Ltd.

• VitalConnect

• ResMed

• Siren

Digital Patient Monitoring Devices Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global digital patient monitoring devices market report on the basis of type, product, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Wireless Sensor Technology

  • mHealth

  • Telehealth

  • Wearable Devices

  • Remote Patient Monitoring

    • Hospital Inpatient

    • Ambulatory Patient

    • Smart Home healthcare

• Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Diagnostic Monitoring Devices

    • Vital Sign Monitors

    • Sleep Monitors

    • Fetal Monitors

    • Neuromonitors

    • Other Monitors

  • Therapeutic Monitoring Devices

    • Insulin Monitors

    • Respiratory Monitors

    • Other Monitors

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • France

    • Germany

    • Italy

    • Spain

    • U.K.

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa (MEA)

    • South Africa

    • Saudi Arabia